{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02060383","recordId":"NCT02060383","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02060383-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02060383.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02060383.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-02-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-02-11","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"93559cebbd5f3dd885d0f6f7a9d19d457c21457a85dcf34b728699c22c77f33b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2014-07-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2014-07-16","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"561dab10cdf8e4913c0fef9c63fcf9070f9d660e83b37fa54bfdc76338d129c5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-01-29","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"0a55439c749e4d1cf7b5d5c4f130223c127876a98a7a48d66f8a28eb40b1544c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2015-06-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-06-05","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"8565343cf6781cde95109ec92b002f893abc1b9486699392398a4b1cfd0e0b1b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2016-01-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-01-22","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"32a5d891ea899ea50dd983c3c3cab9c3159905a19783e08ccc89db7c803dd54c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2016-08-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-08-01","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"d953ed51cbe7f561438f17ed9efdc8e934e40a0bc5ff519a9e94ad2c3b3c2272","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2016-09-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-09-04","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"bb4fb20f391a62b02d0632bd57ce9cb5ccff4f27f9134fdec5c8e05e40e4952f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2016-10-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-07","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"5222c70abcd2310f55a5f3a0273005f6835dfeab740ea73e46814257af8b75e7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2016-11-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-09","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"64010fbba47c72012561f2d5ab5264181e23da8c740db665d4d1002424a4697a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2016-12-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-12-12","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"2299bbfcdb47c54fe8e166b17c9a0a7e4c0753222bb3386d4433a68d3e362d39","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2017-01-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-16","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"b317d1c6bd08b4d76eedbb9dd8f77b91533cfc322e8456b9d71b34e2405da898","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2017-02-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-02-24","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"8b475a55ab1bd0247e58a90b21c62f9941edb713ef828ad6134c79ca0451596d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2017-03-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-24","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"a60764efe0e13426d82ef16e8adf6aadd923c779ca480fea25d6d020e573a425","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","IPDSharing","Oversight","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2017-05-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-05-26","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"4c2e3c19e1c3f10763def28a1d000186b49c0c74efff916f4eaa274b3dbc76bc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","IPDSharing","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2017-06-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-06-13","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"55207f94eef37ab720279fb59a7b900d69cbe66f133f63d63009d3f31aef21d8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2017-07-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-07-05","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"4b4d1ff0ab7b4ea5a949ab1362899af93a8b08c5e4caab6b4a342e3982930e6c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2017-09-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-09-17","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"8e86dbf890622dc652d1e25fd1afb785a3f23e66b53f5bf013eca73a424260bb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2017-09-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-09-26","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"15653510481e870b479ab313e3148fd818dccce0908a27c9f8689ce3a0c9111c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2017-10-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-10-12","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"2afc9913130c011d571ef21eeac925e80c130fedf337f2a1816fc75678e502d9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2017-10-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-10-30","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"2043b351c7dcd5224cb744d050017004918e53f855fd7543d0ef5929c53e75c0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2017-11-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-11-15","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"aa98959651e4d30f84ec03fe20f66b889ab4dba3050d2e26fcd0a9a6f15af1bd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2018-01-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-01-15","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"a29f149ad1264088ee81d5b518834bd894c4ac6764979b9de3130fc7640d7b4a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2018-01-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-01-31","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"ca3924dbf71575ceef2228d603a103fc16c5c9eb6ea39768da3aedb590d52e9a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2018-07-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-07-19","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"9186f5982df74a310e739d15bbe557d8e28b7983dcc2403a21763fe08d448827","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2018-10-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-10-19","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"56268b65b7f8ba26afc4739070a246e59a4e6782d8e3c8a228b1ce1bef5e9028","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2018-10-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2018-10-30","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"f7b0bf5eb7301bda06c85fd83dfb360fc4b1d4c4d2bbbad9f0c2e469b9a1c4d7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Contacts/Locations","Document Section","IPDSharing","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Design","Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2019-05-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-05-07","publishedAt":"2026-08-23","recordId":"NCT02060383","recordSha256":"1b2265a6225c1431e0080191117db58bacc82a20f51414ec377f90f4c56aa7fc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02060383?a=28&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"d6c3a7124a24029cf69023009601534f6138bcfe232c8774f7bb340486b11d9b"}}